Abstract
This study presents data from recent publications on the occurrence of mental disorders during the coronavirus disease-2019 (COVID-19) pandemic and the specifics of providing mental health care under social isolation conditions. The issues of negative psychopathological outcome prevention in persons with high-risk mental disorders are considered, as well as the problems of organizing psychiatric care provision during the pandemic, including the possibility of remote counseling and follow-up. The questions of the pathogenesis of psychopathological symptoms in coronavirus infection are discussed. Particular attention is paid to the adverse effects of COVID-19 therapy, psychotropic drugs interactions, and drug treatment for patients with coronavirus infection. The research results and opinions of Russian and international specialists in the field of mental health that are presented in this review are relevant for medical practitioners working in the pandemic.